Kasia J Lipska MD

Summary

• I am an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). My research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. My current research projects are primarily focused on severe hypoglycemia. I am investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, I seek to develop and implement decision support tools to help clinicians and patients make better decisions about their care. My overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.
  
  In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

The Global Diabetes Epidemic
Within the last few decades, South Asia has experienced a rapid economic transition paralleled by an epidemiological shift in disease patterns. Recently, when I

When Diabetes Treatment Goes Too Far
NEW HAVEN - ONE of my elderly patients has Type 2 diabetes and heart disease. He takes a number of medications, including insulin to control his blood sugar lev

Break Up the Insulin Racket
ONE of my patients - whom I will call Mrs. B - is a 78-year-old who has had Type 2 diabetes for over 30 years. She takes several injections of insulin each day.